Andy Harris

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis

Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley et al. · International Journal for Parasitology Drugs and Drug Resistance · 2018 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis

Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley et al. · Antimicrobial Agents and Chemotherapy · 2017 · 36 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis

Andrew A. Voak, Andy Harris, Zeeshan Qaiser et al. · Antimicrobial Agents and Chemotherapy · 2017 · 31 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B

Gert-Jan Wijnant, Katrien Van Bocxlaer, Amanda Fortes Francisco et al. · Antimicrobial Agents and Chemotherapy · 2018 · 26 citations · Full text

Medicine, Dermatology, Infectious Diseases +17

The metabolism of the 5HT₃antagonists ondansetron, alosetron and GR87442 I: A comparison of<b><i>in vitro</i></b>and<b><i>in vivo</i></b>metabolism and<b><i>in vitro</i></b>enzyme kinetics in rat, dog and human hepatocytes, microsomes and recombinant human enzymes

Graham Somers, Andy Harris, Martin K. Bayliss et al. · Xenobiotica · 2007 · 23 citations

Medicine, Pharmacokinetics, Pharmacology +17